vs
Side-by-side financial comparison of Esperion Therapeutics, Inc. (ESPR) and GRID DYNAMICS HOLDINGS, INC. (GDYN). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $104.1M, roughly 1.6× GRID DYNAMICS HOLDINGS, INC.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs 3.7%). Over the past eight quarters, GRID DYNAMICS HOLDINGS, INC.'s revenue compounded faster (12.0% CAGR vs 10.6%).
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Escape Dynamics, Inc. was a Colorado-based technology company that operated 2010–2015 focused on bringing to market single-stage-to-orbit reusable electromagnetically powered spaceplanes.
ESPR vs GDYN — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $168.4M | $104.1M |
| Net Profit | — | $-1.5M |
| Gross Margin | — | 34.8% |
| Operating Margin | 50.6% | 61.7% |
| Net Margin | — | -1.4% |
| Revenue YoY | 143.7% | 3.7% |
| Net Profit YoY | — | -150.6% |
| EPS (diluted) | $0.32 | $-0.02 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $104.1M | ||
| Q4 25 | $168.4M | $106.2M | ||
| Q3 25 | $87.3M | $104.2M | ||
| Q2 25 | $82.4M | $101.1M | ||
| Q1 25 | $65.0M | $100.4M | ||
| Q4 24 | $69.1M | $100.3M | ||
| Q3 24 | $51.6M | $87.4M | ||
| Q2 24 | $73.8M | $83.0M |
| Q1 26 | — | $-1.5M | ||
| Q4 25 | — | $306.0K | ||
| Q3 25 | $-31.3M | $1.2M | ||
| Q2 25 | $-12.7M | $5.3M | ||
| Q1 25 | $-40.5M | $2.9M | ||
| Q4 24 | — | $4.5M | ||
| Q3 24 | $-29.5M | $4.3M | ||
| Q2 24 | $-61.9M | $-817.0K |
| Q1 26 | — | 34.8% | ||
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 33.3% | ||
| Q2 25 | — | 34.1% | ||
| Q1 25 | — | 36.8% | ||
| Q4 24 | — | 36.9% | ||
| Q3 24 | — | 37.4% | ||
| Q2 24 | — | 35.6% |
| Q1 26 | — | 61.7% | ||
| Q4 25 | 50.6% | 0.5% | ||
| Q3 25 | -11.4% | -0.2% | ||
| Q2 25 | 8.6% | -0.1% | ||
| Q1 25 | -34.0% | -2.0% | ||
| Q4 24 | -6.4% | 1.3% | ||
| Q3 24 | -31.0% | 2.4% | ||
| Q2 24 | 3.5% | 0.0% |
| Q1 26 | — | -1.4% | ||
| Q4 25 | — | 0.3% | ||
| Q3 25 | -35.9% | 1.1% | ||
| Q2 25 | -15.4% | 5.2% | ||
| Q1 25 | -62.2% | 2.9% | ||
| Q4 24 | — | 4.5% | ||
| Q3 24 | -57.2% | 4.9% | ||
| Q2 24 | -83.9% | -1.0% |
| Q1 26 | — | $-0.02 | ||
| Q4 25 | $0.32 | $0.01 | ||
| Q3 25 | $-0.16 | $0.01 | ||
| Q2 25 | $-0.06 | $0.06 | ||
| Q1 25 | $-0.21 | $0.03 | ||
| Q4 24 | $-0.14 | $0.06 | ||
| Q3 24 | $-0.15 | $0.05 | ||
| Q2 24 | $-0.33 | $-0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $167.9M | $327.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-302.0M | $530.1M |
| Total Assets | $465.9M | $605.0M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $327.5M | ||
| Q4 25 | $167.9M | $342.1M | ||
| Q3 25 | $92.4M | $338.6M | ||
| Q2 25 | $86.1M | $336.8M | ||
| Q1 25 | $114.6M | $325.5M | ||
| Q4 24 | $144.8M | $334.7M | ||
| Q3 24 | $144.7M | $231.3M | ||
| Q2 24 | $189.3M | $256.0M |
| Q1 26 | — | $530.1M | ||
| Q4 25 | $-302.0M | $542.1M | ||
| Q3 25 | $-451.4M | $537.7M | ||
| Q2 25 | $-433.5M | $532.2M | ||
| Q1 25 | $-426.2M | $517.4M | ||
| Q4 24 | $-388.7M | $517.8M | ||
| Q3 24 | $-370.2M | $400.2M | ||
| Q2 24 | $-344.2M | $388.4M |
| Q1 26 | — | $605.0M | ||
| Q4 25 | $465.9M | $612.9M | ||
| Q3 25 | $364.0M | $613.2M | ||
| Q2 25 | $347.1M | $608.9M | ||
| Q1 25 | $324.0M | $590.9M | ||
| Q4 24 | $343.8M | $592.2M | ||
| Q3 24 | $314.1M | $477.3M | ||
| Q2 24 | $352.3M | $443.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $45.2M | — |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 0.0% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $45.2M | $9.9M | ||
| Q3 25 | $-4.3M | $7.0M | ||
| Q2 25 | $-31.4M | $14.4M | ||
| Q1 25 | $-22.6M | $9.4M | ||
| Q4 24 | $-35.0M | $7.1M | ||
| Q3 24 | $-35.3M | $9.2M | ||
| Q2 24 | $-7.2M | $10.7M |
| Q1 26 | — | — | ||
| Q4 25 | — | $6.1M | ||
| Q3 25 | — | $2.9M | ||
| Q2 25 | — | $10.2M | ||
| Q1 25 | — | $6.0M | ||
| Q4 24 | — | $4.4M | ||
| Q3 24 | $-35.5M | $5.9M | ||
| Q2 24 | $-7.3M | $8.0M |
| Q1 26 | — | — | ||
| Q4 25 | — | 5.7% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | 10.1% | ||
| Q1 25 | — | 6.0% | ||
| Q4 24 | — | 4.4% | ||
| Q3 24 | -68.7% | 6.8% | ||
| Q2 24 | -9.9% | 9.7% |
| Q1 26 | — | — | ||
| Q4 25 | 0.0% | 3.6% | ||
| Q3 25 | 0.0% | 3.9% | ||
| Q2 25 | 0.0% | 4.1% | ||
| Q1 25 | 0.0% | 3.3% | ||
| Q4 24 | 0.0% | 2.6% | ||
| Q3 24 | 0.3% | 3.7% | ||
| Q2 24 | 0.1% | 3.2% |
| Q1 26 | — | — | ||
| Q4 25 | — | 32.34× | ||
| Q3 25 | — | 5.92× | ||
| Q2 25 | — | 2.73× | ||
| Q1 25 | — | 3.21× | ||
| Q4 24 | — | 1.56× | ||
| Q3 24 | — | 2.15× | ||
| Q2 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
GDYN
Segment breakdown not available.
